| | Process | LDL-apoB-100 | Apo(a) | Region | References |
| | Thrombosis | | | | | | (i) Platelet aggregation | | | | [11–17] | | (ii) tissue factor pathway | — | | | [19–21] | | (iii) plasminogen activation | — | | KIV type 10, KV | [8, 20, 23–28] | | (iv) TGF activation | × | | KIV type 9 | [34–37] | | (v) TGF production | — | | KIV type 10, KV | [37] | | Inflammation | | | | | | (i) Oxidised phospholipids | × | | KV | [44–46] | | (ii) monocyte migration | | | | [19, 51, 53] | | (iii) monocyte adhesion | × | | KIV type 10 | [19] | | Vascular remodelling | | | | | | (i) SMC proliferation | | | KIV type 9 | [35, 36, 58, 62] | | (ii) SMC migration | — | | KIV type 9 | [36] | | (iii) EC proliferation | | | KIV type 10, KV | [37, 64, 65] | | (iv) EC migration | | | KIV type 10, KV | [37, 65] | | (v) EC contraction | — | | KIV type 10 | [70] |
|
|